Joan H. Parks, Elaine M. Worcester, R. Corey O'Connor, Fredric L. Coe 

Slides:



Advertisements
Similar presentations
Volume 72, Issue 1, Pages (July 2007)
Advertisements

Kamyar Kalantar-Zadeh  Kidney International 
Kidney stones are common after bariatric surgery
Volume 63, Issue 3, Pages (March 2003)
Volume 54, Issue 2, Pages (August 1998)
Volume 81, Issue 11, Pages (June 2012)
Volume 64, Issue 6, Pages (December 2003)
Jennifer L. Ennis, John R. Asplin  International Journal of Surgery 
Recent advances in the pathophysiology of nephrolithiasis
Sushrut S. Waikar, Venkata S. Sabbisetti, Joseph V. Bonventre 
Volume 61, Issue 3, Pages (March 2002)
Volume 78, Issue 3, Pages (August 2010)
Volume 56, Issue 4, Pages (October 1999)
Determinants of phosphorus mobilization during hemodialysis
Volume 64, Issue 6, Pages (December 2003)
Volume 83, Issue 6, Pages (June 2013)
Kidney stones are common after bariatric surgery
Reassessment of the care of the patient with chronic kidney disease
Volume 57, Issue 5, Pages (May 2000)
Volume 55, Issue 1, Pages (January 1999)
Volume 76, Issue 10, Pages (November 2009)
Volume 72, Issue 1, Pages (July 2007)
Urinary cystine excretion and capacity in patients with cystinuria
Volume 54, Issue 2, Pages (August 1998)
Volume 65, Issue 5, Pages (May 2004)
Effect of acidosis on urine supersaturation and stone formation in genetic hypercalciuric stone-forming rats  David A. Bushinsky, Marc D. Grynpas, John.
Response to is the reduction in urea distribution volume over time in clinically stable dialysis patients real?  S. Andrulli, S. Di Filippo, F. Locatelli 
Erratum American Journal of Kidney Diseases
Kamyar Kalantar-Zadeh  Kidney International 
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
Volume 78, Issue 6, Pages (September 2010)
Jianing Yu, David Ferster  Neuron 
Volume 66, Issue 2, Pages (August 2004)
Volume 56, Issue 2, Pages (August 1999)
How to interpret the eGFR in patients with small body surface area
Anti-glomerular basement membrane autoantibodies against different target antigens are associated with disease severity  Juan Zhao, Zhao Cui, Rui Yang,
Volume 76, Issue 3, Pages (August 2009)
John R. Asplin, Joan H. Parks, Yashushi Nakagawa, Fredric L. Coe, M.D. 
Volume 56, Issue 3, Pages (September 1999)
Volume 87, Issue 2, Pages (February 2015)
Kt/V underestimates the hemodialysis dose in women and small men
Volume 69, Issue 3, Pages (February 2006)
Volume 66, Issue 3, Pages (September 2004)
Fructose intake as a risk factor for kidney stone disease
Volume 60, Issue 4, Pages (October 2001)
Volume 67, Issue 1, Pages (January 2005)
Volume 72, Issue 1, Pages 8-10 (July 2007)
The effect of fruits and vegetables on urinary stone risk factors
Volume 60, Issue 1, Pages (July 2001)
Volume 93, Issue 1, Pages (January 2018)
Volume 63, Issue 6, Pages (June 2003)
Volume 63, Issue 2, Pages (February 2003)
Volume 64, Issue 6, Pages (December 2003)
Harold M. Aukema, Ihsan Housini  Kidney International 
Homocysteine, renal function, and risk of cardiovascular disease
Yasunori Kitamoto, Katsuhiko Matsuo, Kimio Tomita  Kidney International 
Post-transplant hypophosphatemia: Tertiary ‘Hyper-Phosphatoninism’?
Association of urinary pH with body weight in nephrolithiasis
Volume 81, Issue 11, Pages (June 2012)
Cystinuria subtype and the risk of nephrolithiasis1
Calcium phosphate supersaturation regulates stone formation in genetic hypercalciuric stone-forming rats  David A. Bushinsky, M.D., Walter R. Parker,
Volume 80, Issue 10, Pages (November 2011)
Treatment of the primary hyperoxalurias: A new chapter
Replacing the short ammonium chloride test
The hypothesis that abnormal BH4 metabolism impairs kidney function
Chronic metabolic acidosis in azotemic rats on a high-phosphate diet halts the progression of renal disease  Aquiles Jara, Arnold J. Felsenfeld, Jordi.
Volume 63, Issue 3, Pages (March 2003)
Plasma concentration and urinary excretion of N-terminal proatrial natriuretic peptides in patients with kidney diseases  Martina Franz, Wolfgang Woloszczuk,
Volume 56, Issue 5, Pages (November 1999)
Biochemical profile of idiopathic uric acid nephrolithiasis
Presentation transcript:

Urine stone risk factors in nephrolithiasis patients with and without bowel disease  Joan H. Parks, Elaine M. Worcester, R. Corey O'Connor, Fredric L. Coe  Kidney International  Volume 63, Issue 1, Pages 255-265 (January 2003) DOI: 10.1046/j.1523-1755.2003.00725.x Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 1 Distributions of stone rates. Untransformed stone rates (x-axes, A) for bowel patients (top) and the stone rate reference patients (bottom) were not normally distributed as shown by lack of linearity when plotted against a normal distribution function (y-axes). When log transformed (B), rates were reasonably linear, indicating a fit to the normal distribution function. For bowel patients, deviation from normality was not significant (Kolmogrov-Smirnov Lilliefors, P = 0.95). For the much larger stone rate reference population, deviation was significant (P < 0.00001) although the maximal difference (0.046) was not remarkably different from the maximal difference for the bowel disease patients (0.033). Kidney International 2003 63, 255-265DOI: (10.1046/j.1523-1755.2003.00725.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 2 (A) Percent calcium oxalate (○) in stones formed by patients, none of whose stones contained any uric acid, and percent uric acid (•) in stones formed by patients any of whose stones contained uric acid. For the no uric acid groups (○), the remainder of the stones is comprised of calcium phosphate. The five groups are distributed along the y-axis. Differences in frequency and percent uric acid are in the Results section. (B) Time (years) between the diagnosis of bowel disease and formation of first stone (x-axis) versus bowel disease patient group (y-axis). Positive values indicate that stone formation began after diagnosis of bowel disease. Symbols are: (•) means ± SEM; (○) individual patients. Groups are defined in the Methods section: Bypass (6 ± 2) differed from Both (13 ± 2) and Small Only (11 ± 1). Colon Only (6 ± 1) differed from Both. Patients with no surgery (6 ± 2) differed from no other group (P values are in the text). Kidney International 2003 63, 255-265DOI: (10.1046/j.1523-1755.2003.00725.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 3 (A) Quantile plot of creatinine clearance for women (♀) and men (♂) were below same sex risk factor reference patients (adjacent darker lines). Dashed line intersects distributions at their median. (B) Quantile plots of log transformed stone rates for all five bowel patient groups exceed rates for the stone rate reference group (dark line). Patients with Bypass (×), Both (○), Colon Only (+), Small Only (▵), and None (▿) did not differ from each other. Kidney International 2003 63, 255-265DOI: (10.1046/j.1523-1755.2003.00725.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 4 Mean values of supersaturation. Supersaturation for calcium oxalate (z axis, height of spike) and supersaturation for calcium phosphate and uric acid (y and x axes, feet of spike) were similar between patients with no surgery (None) and the risk factor reference population (Reference). The other groups differed from the risk factor reference population (comparisons are in the Results section). Symbols are: (♦) reference; (▾) none; (▴) small only; (×) bypass; (•) both; (+) colon only. Kidney International 2003 63, 255-265DOI: (10.1046/j.1523-1755.2003.00725.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 5 Factors that determine supersaturation. Quantile plots show the principle factors as determined by multivariate analysis. The risk factor reference population is shown by the heavy line. Dashed lines intersect with each distribution at its median. Symbols are: Bypass (×), Both (○), Colon Only (+), Small Only (◃), None (▿). All are log transformed except for urine pH and uric acid excretion for display purposes. Kidney International 2003 63, 255-265DOI: (10.1046/j.1523-1755.2003.00725.x) Copyright © 2003 International Society of Nephrology Terms and Conditions

Figure 6 Urine and serum nutrient values. Quantile plots show the urine and serum factors that are different from the risk factor reference patients. Dashed lines intersect with each distribution at its median. Symbols are: Bypass (×), Both (○), Colon Only (+), Small Only (◃), None (▿). Kidney International 2003 63, 255-265DOI: (10.1046/j.1523-1755.2003.00725.x) Copyright © 2003 International Society of Nephrology Terms and Conditions